GLP-1s are not currently banned by WADA, but they are being monitored
It prevents large spikes in glucose after meals by slowing the release of sugars into the bloodstream
The Clinical Evidence: What Trials Actually Showed Evaluating AOD-9604 before-and-after outcomes requires separating animal data from human data
Rethink Prescribing Criteria: Current weight-loss thresholds for determining treatment success may be misleading
Domestic sourcing means faster delivery, typically two to four business days to most major Canadian cities including Toronto, Calgary, Montreal, and Ottawa
Of note is that tirzepatide was previously reported to cause biased signaling at GLP-1R in favor of cAMP response over -arrestin recruitment in the presence of 0.1% casein 39 , which was confirmed in the present study showing that non-acylated tirzepatide elicited better cAMP responses (EC 50 = 0.90 pM for 0.1% casein and 4.66 pM for 0.1% BSA) than that of tirzepatide (EC 50 = 3.05 pM for 0.1% casein and 103.10 pM for 0.1% BSA) (Supplementary Table 11) highlighting the impact of acylation on their pharmacological properties